These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9079190)

  • 41. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic polymorphism of CYP2A6 in the German population.
    Bourian M; Gullstén H; Legrum W
    Toxicology; 2000 Apr; 144(1-3):129-37. PubMed ID: 10781880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 57 varieties: the human cytochromes P450.
    Lewis DF
    Pharmacogenomics; 2004 Apr; 5(3):305-18. PubMed ID: 15102545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular modeling of cytochrome P450 and drug metabolism.
    Wang JF; Chou KC
    Curr Drug Metab; 2010 May; 11(4):342-6. PubMed ID: 20446905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of xenobiotics metabolism, genotoxicity, and carcinogenicity using Cyp2e1(-/-) mice.
    Ghanayem BI; Hoffler U
    Curr Drug Metab; 2007 Oct; 8(7):728-49. PubMed ID: 17979661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytochrome P450 and xenobiotic receptor humanized mice.
    Gonzalez FJ; Yu AM
    Annu Rev Pharmacol Toxicol; 2006; 46():41-64. PubMed ID: 16402898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenetics of the major polymorphic metabolizing enzymes.
    Daly AK
    Fundam Clin Pharmacol; 2003 Feb; 17(1):27-41. PubMed ID: 12588628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular basis of polymorphic drug metabolism.
    Daly AK
    J Mol Med (Berl); 1995 Nov; 73(11):539-53. PubMed ID: 8751138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacogenetics-based new therapeutic concepts.
    Roots I; Gerloff T; Meisel C; Kirchheiner J; Goldammer M; Kaiser R; Laschinski G; Brockmöller J; Cascorbi I; Kleeberg U; Hildebrandt AG
    Drug Metab Rev; 2004 Oct; 36(3-4):617-38. PubMed ID: 15554239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression alterations of cytochromes P4501A1, 2E1, and 3A, and their receptors AhR and PXR caused by 1-octyl-3-methylimidazolium chloride in mouse mammary carcinoma cells.
    Li X; Ma J; Jing C; Wang J
    Chemosphere; 2013 Nov; 93(10):2488-92. PubMed ID: 24094773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human cytochrome P450: possible roles of drug-metabolizing enzymes and polymorphic drug oxidation in addiction.
    Gonzalez FJ
    NIDA Res Monogr; 1991; 111():202-13. PubMed ID: 1775182
    [No Abstract]   [Full Text] [Related]  

  • 55. [Role of human cytochrome P-450 enzymes in the metabolism of xenobiotics].
    Monostory K; Vereczkey L
    Acta Pharm Hung; 1995 Sep; 65(5):147-56. PubMed ID: 7484161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitochondrial Biotransformation of Drugs and other Xenobiotics.
    Orhan H; Karakuş F; Ergüç A
    Curr Drug Metab; 2021; 22(8):657-669. PubMed ID: 34182906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
    Schulz T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1004-10. PubMed ID: 17013775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.
    Guengerich FP
    Chem Res Toxicol; 2017 Jan; 30(1):2-12. PubMed ID: 27472660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
    Serpe L; Canaparo R; Scordo MG; Spina E
    Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional consequences of polymorphism of xenobiotic metabolising enzymes.
    Ingelman-Sundberg M
    Toxicol Lett; 1998 Dec; 102-103():155-60. PubMed ID: 10022248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.